KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors-Reference-Cited by-同舟云学术

KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors

Published:2012-05-31 Issue:5 Volume:7 Page:e38033
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Garrido-Laguna Ignacio,Hong David S.,Janku Filip,Nguyen Ly M.,Falchook Gerald S.,Fu Siqing,Wheler Jenifer J.,Luthra Rajyalakshmi,Naing Aung,Wang Xuemei,Kurzrock Razelle

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference19 articles.

1. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.;RG Amado;J Clin Oncol,2008

2. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.;E Van Cutsem;N Engl J Med,2009

3. Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab.;W De Roock;JAMA,2010

4. PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.;A Sartore-Bianchi;Cancer Res,2009

5. PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.;H Prenen;Clin Cancer Res,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study;Current Oncology;2024-01-03

2. Colorectal cancer: understanding of disease;Colorectal Cancer;2024

3. Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review;The Oncologist;2023-07-11

4. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?;International Journal of Molecular Sciences;2021-09-23

5. Mucin in cancer: a stealth cloak for cancer cells;BMB Reports;2021-07-31